Table 2 Clinical and histopathological characteristics of cervical cancer patients in Tikur Anbesa Specialized Hospital oncology center, Ethiopia (n = 634)
Covariates | Code | Status at last contact | Total No (%) | |
|---|---|---|---|---|
Censored No (%) | Death No (%) | |||
FIGO stage | Stage I | 59 (93.7) | 4 (6.3) | 63 (9.9) |
Stage II | 132 (83.5) | 26 (16.5) | 158 (24.9) | |
Stage III | 184 (72.2) | 71 (27.8) | 255 (40.2) | |
Stage IV | 73 (46.2) | 85 (53.8) | 158 (24.9) | |
Histopathology | Squamous cell | 406 (70.7) | 168 (29.3) | 574 (90.5) |
Adenocarcinoma | 42 (70.0) | 18 (30.0) | 60 (9.5) | |
Anemic status | Yes | 184 (57.0) | 139 (43.0) | 323 (50.9) |
No | 264 (84.9) | 47 (15.1) | 311 (49.1) | |
Comorbidity | Yes | 117 (55.2) | 95 (44.8) | 214 (33.4) |
No | 331 (78.4) | 91 (21.6) | 422 (66.6) | |
Types of comorbidity | HIV | 56 (47.5) | 62 (52.5) | 118 (55) |
Hypertension | 29 (59.2) | 20 (40.8) | 49 (23) | |
Others | 33 (70.2) | 14 (29.8) | 47 (22) | |